MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)

Clinical trial NCT03412292 · UNKNOWN

Trial details

NCT number: NCT03412292
Sponsor: Maxinovel Pty., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia (AML)

Start date: 2018-08-01
Primary completion: 2022-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.